NCT03622697

Brief Summary

Currently, physicians have several options in addressing the anatomic and physiologic sequela of facial paralysis. However, strategies to address the psychologic and coping ability for patients have not been investigated. The goal is to investigate the effect of mindfulness meditation on social functioning in patients with facial paralysis. This study will also explore whether increasing social functioning in patients with facial paralysis will improve overall quality of life. These questions will be answered using a randomized controlled trial.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Jul 2021

Geographic Reach
1 country

2 active sites

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 3, 2018

Completed
6 days until next milestone

First Posted

Study publicly available on registry

August 9, 2018

Completed
2.9 years until next milestone

Study Start

First participant enrolled

July 1, 2021

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2022

Completed
Last Updated

October 19, 2021

Status Verified

June 1, 2021

Enrollment Period

1.5 years

First QC Date

August 3, 2018

Last Update Submit

October 12, 2021

Conditions

Keywords

mindfulnessmeditationfacial paralysisquality of lifesocial functioning

Outcome Measures

Primary Outcomes (3)

  • Changes in Social Functioning as assessed by University of California, Los Angeles 3-point loneliness scale

    University of California, Los Angeles 3-point loneliness scale - minimum score 0, maximum score 100 assessing how often one feels socially isolated, higher indicating greater loneliness

    Change from baseline at 2 weeks, 4 weeks, and 6 weeks

  • Changes in Social Functioning as assessed by Facial Disability Index

    Facial disability index (social functioning portion) - categorical responses ranging from "never" to "all of the time" for social problems associated with facial muscle function over the past month to measure social functioning; the minimum to maximum score range for social functioning is 5 to 30 with a higher score indicating greater social functioning

    Change from baseline at 2 weeks, 4 weeks, and 6 weeks

  • Changes in Social Functioning as assessed by a Social Functioning Visual Analog Scale

    Social functioning visual analog scale - single-item questionnaire ranging from 0 to 100 with greater numbers indicating more comfort in socializing with others

    Change from baseline at 2 weeks, 4 weeks, and 6 weeks

Secondary Outcomes (4)

  • Changes in Reported Quality of Life as assessed by a Visual Analog Scale

    Change from baseline at 2 weeks, 4 weeks, and 6 weeks

  • Changes in Anxiety assessed by the State-Trait Anxiety Inventory

    Change from baseline at 2 weeks, 4 weeks, 6 weeks

  • Changes in Mindfulness as measured using the Cognitive and Affective Mindfulness Scale-Revised

    Change from baseline at 2 weeks, 4 weeks, 6 weeks

  • Changes in Physical Functioning as assessed by Facial Disability Index

    Change from baseline at 2 weeks, 4 weeks, 6 weeks

Study Arms (2)

Mindfulness Meditation Arm

EXPERIMENTAL

Mindfulness meditation intervention: patients will be asked to complete a guided mindfulness meditation phone application intervention.

Behavioral: Mindfulness Meditation Phone Application

Non-Intervention Arm

NO INTERVENTION

Patients assigned to the non-intervention arm will not be instructed to use a mindfulness meditation phone application and instead will listen to educational materials.

Interventions

Mindfulness meditation intervention: patients will be asked to complete a guided mindfulness meditation intervention using a phone application for at least 4 weeks with periodic survey assessments using validated psychometric tools.

Mindfulness Meditation Arm

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients older than 18 years of age
  • Must have any-cause facial paralysis

You may not qualify if:

  • Patients younger than 18 years old
  • Non-English speakers
  • Patients without smart-phone access
  • Patients with autism
  • Patients with schizophrenia
  • Patients with an affective psychiatric condition

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Johns Hopkins Hospital

Baltimore, Maryland, 21287, United States

Location

Johns Hopkins - Green Spring Station

Lutherville-Timonium, Maryland, 21093, United States

Location

Related Publications (3)

  • Hoge EA, Bui E, Palitz SA, Schwarz NR, Owens ME, Johnston JM, Pollack MH, Simon NM. The effect of mindfulness meditation training on biological acute stress responses in generalized anxiety disorder. Psychiatry Res. 2018 Apr;262:328-332. doi: 10.1016/j.psychres.2017.01.006. Epub 2017 Jan 26.

    PMID: 28131433BACKGROUND
  • Simkin DR, Black NB. Meditation and mindfulness in clinical practice. Child Adolesc Psychiatr Clin N Am. 2014 Jul;23(3):487-534. doi: 10.1016/j.chc.2014.03.002.

    PMID: 24975623BACKGROUND
  • Nellis JC, Ishii M, Byrne PJ, Boahene KDO, Dey JK, Ishii LE. Association Among Facial Paralysis, Depression, and Quality of Life in Facial Plastic Surgery Patients. JAMA Facial Plast Surg. 2017 May 1;19(3):190-196. doi: 10.1001/jamafacial.2016.1462.

    PMID: 27930763BACKGROUND

MeSH Terms

Conditions

Facial ParalysisSocial Adjustment

Condition Hierarchy (Ancestors)

Mouth DiseasesStomatognathic DiseasesParalysisNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsSocial BehaviorBehavior

Study Officials

  • Lisa Ishii, MD, MHS

    Johns Hopkins University

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 3, 2018

First Posted

August 9, 2018

Study Start

July 1, 2021

Primary Completion

December 31, 2022

Study Completion

December 31, 2022

Last Updated

October 19, 2021

Record last verified: 2021-06

Data Sharing

IPD Sharing
Will not share

Locations